ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers.

Georg Karpel-Massler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.